The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership-based, IRS-approved 501 (c) (3) non-profit research and educational organization. We assist scientists to design, fund, obtain approval for and report on studies into the risks and benefits of MDMA, psychedelic drugs and marijuana.

MAPS' mission is to sponsor scientific research designed to develop psychedelics and marijuana into FDA-approved prescription medicines, and to educate the public honestly about the risks and benefits of these drugs. Read our strategy statement for more information.

We need your support so together we can make a difference. In addition to general membership donations, MAPS is seeking to raise funds for specific research projects. These are our funding priorities and here are our financial reports.

For background reading, see MAPS President Rick Doblin's doctoral dissertation (Harvard, Kennedy School of Govt., 2001) "Regulation of the Medical Use of Psychedelics and Marijuana," visit our media and audio/visual archives, or peruse the latest issue of the MAPS Bulletin and our monthly news update.

	7/30/10	The Journal of Psychopharmacology's publication of MAPS' MDMA/PTSD study led to at least 138 media articles!
	7/19/10	On July 19, the Journal of Psychopharmacology published the results of our U.S. MDMA/PTSD pilot study.
	7/18/10	Michael Mithoefer, M.D. shares the results from his MDMA/PTSD pilot study in this video from Psychedelic Science in the 21st Century.
	7/5/10	MAPS President Rick Doblin, Ph.D. gave an informative and visionary Google Tech Talk about the psychedelic research renaissance.
	7/1/10	On July 1, MAPS won the Guidestar / Great Nonprofits Health Campaign! We received more reviews from our supporters than 115 other nonprofits in the contest.
	6/11/10	On June 11, MAPS Executive Director Rick Doblin, Ph.D. was interviewed on Progressive Radio Network's "Of Consuming Interest."
	5/5/10	Rick Doblin, Ph.D's opening and closing remarks and Andrew Weil, M.D.'s talk at the Psychedelic Science conference are available for viewing on the conference page.

---

ALBERT HOFMANN
11 January 1906 - 29 April 2008

MAPS is pleased to present the original work of two amazing Visionary Artists: Roberto Venosa and Dean Chamberlain. We are now proudly offering four special signed and numbered limited-edition prints from Dean Chamberlain's Psychedelic Pioneers series (at left), as well as limited-edition prints of Robert Venosa's portrait of Albert Hofmann, signed by Albert Hofmann himself (at right). Proceeds from the sale of these portraits will be equally divided between MAPS-sponsored psychedelic research and the respective artists.

Both Dean Chamberlain's portraits of Albert Hofmann, Laura Huxley, Ann & Sasha Shulgin and Ram Dass as well as Roberto Venosa's portrait of Albert Hofmann are all available for purchase in the MAPS Online Store. These portraits are not only a good investment and would look great on your wall, but they are also a major fundraising tool for MAPS' research projects!